Society of Interventional Radiology names Parag J. Patel, MD, MS, FSIR, president for 2022–2023

Parag J. Patel, MD, MS, FSIR, an interventional radiologist and professor of radiology at the Medical College of Wisconsin, Milwaukee, assumed the office of president of the Society of Interventional Radiology (SIR) on June 14, during the society’s annual Members’ Business Meeting. The meeting was held during the SIR 2022 Annual Scientific Meeting in Boston.

“As SIR approaches its 50th anniversary, we are transforming how we do business to meet the needs of our diverse membership, giving energy to ideas to help our members thrive in their chosen practice models,” said Patel. “Throughout the pandemic, SIR has become more agile and responsive. We will build on that momentum to deliver training, resources and tools that empower competitive IR teams and enable the best patient care possible.”

Other incoming officers of SIR’s 2022–2023 Executive Council include President-elect Alda L. Tam, MD, FSIR, MD Anderson Cancer Center, Houston; newly appointed Secretary Robert J. Lewandowski, MD, FSIR, Northwestern Medicine, Chicago; and Immediate Past-president Matthew S. Johnson, MD, FSIR, Indiana University School of Medicine, Indianapolis.
New and re-elected members of the SIR Executive Council are:

Raymond W. Liu, MD, FSIR—SIR and SIR Foundation Treasurer
Nishita Kothary, MD, FSIR—Councilor at-large
C. Matthew Hawkins, MD, FSIR—Health Policy and Economics Division Councilor
Rahul A. Sheth, MD—Interventional Oncology Councilor
Following the 2022 Annual Member’s Business Meeting, Theresa M. Caridi, MD, FSIR, associate professor and division director of interventional radiology at the University of Alabama At Birmingham, assumed the role of chair of the SIR Foundation Board of Directors and Katharine L. Krol, MD, FSIR, the past chair.

“For more than 30 years, SIR Foundation has ensured the promise and the practice of IR are supported by evidence and patient outcomes,” said Caridi. “With the launch of new grant programs and a new clinical trials network, SIR Foundation continues to advance IR through research that furthers IR knowledge, priorities, and partnerships, expanding access to IR for patients.”

SIR Foundation also appointed the following members to its Board of Directors:

Maureen P. Kohi, MD, FSIR—Vice Chair
Govindarajan Srimathveeravalli, PhD—Scientist Member
Amy C. Taylor, MD—Development Division Chair

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”